Your Family Naturopath

17/08/2025

Thank you Peter & Franzisca from for these beautiful Australian Grown exotic mushrooms 🍄‍🟫 😍 🙏🏽🙏🏽🥰 grown locally in FNQ at Lakeland Check out your local produce store to buy them and support this wonderful farming family and enjoy the many health benefits from the many delicious varieties such as king oyster, shiitake and shimeji 😋💗✨

13/08/2025

Do yourself a favour and listen to optimiseyour health!! Simon Mills is one of our modern forefathers of herbal medicine alongside Kerry Bone. I’ve seen his presentation live at seminars and symposiums he offers simple herbal home remedies that are scientifically backed 💗🌿✨

Is the root of every illness your gut? Could 5 simple herbs replace your medicine cabinet? Natural remedy expert Simon Mills reveals the herbal medicines tha...

12/08/2025

Cheers to all those people chugging back their herbal mix this morning!!! 🌿🤭😜

04/08/2025

✨💗✨

17/07/2025

02/07/2025

My daughter and I had the absolute pleasure to help Liz Tonkin from Tonketti Trading shoot her stunning new Midnight Tapestry range. I adore the style, feel and wear of Tonketti’s clothing , in fact I still have pieces from years ago in my cupboard that don’t date! Make a troop up to our little village in Kuranda and find some treasure at Tonketti fab for all ages, sizes and easy, breezy styles country, beach, boho etc 💗✨

18/06/2025

💗🍒💗

Daily consumption of Montmorency tart cherry juice significantly reduced gut inflammation and improved quality of life in ulcerative colitis (UC) patients in a small clinical trial.

Following positive clinical trials of bilberry extract in UC patients, 35 people with UC were randomly assigned to receive either placebo or a Montmorency tart cherry juice concentrate (chosen for its high anthocyanin content, like bilberries), of which they drank 30 mL twice a day for 6 weeks. The primary outcome and health-related quality of life was measured via the Inflammatory Bowel Disease Quality of Life Questionnaire (IBDQ). Secondary measures included other health-related questionnaires, blood biomarkers and faecal samples.

There were significantly greater improvements in the IBDQ (improved by 9%) and the simple clinical colitis activity index in the tart cherry trial arm compared to placebo. In addition, the reduction in faecal calprotectin was significantly greater in the tart cherry trial arm compared to placebo (by 40%), although the trial groups were not well matched for this parameter, with much higher starting levels in the treated group. Blood biomarkers of inflammation were not changed, and neither were faecal microbiome measures of alpha and beta diversity.

Study co-author Lindsay Bottoms, Professor in Exercise and Health Sciences and Head of Centre for Research in Psychology and Sports at the University of Hertfordshire, said: “Montmorency tart cherries have greater anthocyanin levels than most other dark fruits, so we wanted to investigate if cherry juice supplementation had any clinical benefit in patients with mild-to-moderate colitis.”

Previous analysis has shown that 30 mL of the Montmorency tart cherry concentrate contains 9.117 mg/mL of anthocyanins, which is equivalent to eating about 100 cherries.

For more information see: https://pubmed.ncbi.nlm.nih.gov/40003718/
and
https://scitechdaily.com/drinking-this-fruit-juice-may-cut-gut-inflammation-by-40/

12/06/2025

Rusty’s delights 😋

19/05/2025

Two recent studies presented at the American Stroke Association’s International Stroke Conference 2025 have highlighted the role of oral health in cardiovascular disease. A study in Japan found elevated levels of Streptococcus anginosus, a common mouth and gut bacterium, in the gut of recent stroke survivors. Over two years, stroke patients with high levels of this bacteria had a greater risk of death or another major cardiovascular event. The findings suggest that analysing oral and gut bacteria could help assess stroke risk, and that targeting harmful bacteria through new treatments and better dental hygiene may aid in stroke prevention.

“In the future, if there was a quick test to detect harmful bacteria in the mouth and gut, we could use the information to help calculate stroke risk. Targeting these specific harmful oral bacteria may help prevent stroke,” said Shuichi Tonomura, lead author of the study and staff physician in the department of neurology at the National Cerebral and Cardiovascular Centre in Osaka, Japan.

Previously, these researchers found that a different bacterium, the one that causes tooth decay, Streptococcus mutans, was associated with a higher risk of bleeding inside the brain.

The second study suggests that flossing at least once a week may lower the risk of stroke and atrial fibrillation (AFib), independent of other oral hygiene habits. Researchers believe the benefits stem from reduced inflammation and infection, though further studies are needed. However, while the study found a correlation between flossing and lower stroke risk, this does not prove that flossing directly causes the reduction.

“A recent global health report revealed that oral diseases, such as untreated tooth decay and gum disease, affected 3.5 billion people in 2022, making them the most widespread health conditions,” said study lead author Souvik Sen, chair of the Department of Neurology, Prisma Health Richland Hospital and the University of South Carolina School of Medicine in Columbia, South Carolina. “We aimed to determine which oral hygiene behaviour, dental flossing, brushing, or regular dentist visits, has the greatest impact on stroke prevention.”

The Atherosclerosis Risk in Communities (ARIC) study, one of the first large-scale investigations of this kind in the US, assessed the home use of dental floss through a structured questionnaire of more than 6,000 people over 25 years. Flossing was associated with a 22% lower risk of ischemic stroke, 44% lower risk of cardioembolic stroke (blood clots traveling from the heart), and 12% lower risk of AFib. The associated lower risk was independent of regular brushing and routine dental visits or other oral hygiene behaviours. Increasing the frequency of flossing conferred a greater chance of stroke risk reduction. Flossing was also associated with a lower chance of cavities and periodontal disease. Researchers were surprised by the reduction of AFib associated with flossing.

For more information see: https://scitechdaily.com/common-mouth-bacteria-linked-to-higher-stroke-risk/
and
https://scitechdaily.com/new-study-reveals-that-flossing-could-reduce-your-risk-of-stroke-by-22/

16/05/2025

Yummm!! Came home starving from a big morning at the markets and park time with the little man - quickly unpacked fruit and veg and whipped up a delicious salad from all the market goodies 😄💗🌿✨
❤️stir fry button mushies & kale
❤️olives and pickles
❤️garden fresh lettuce
❤️carrot and creamy avo
❤️big drizzle of olive oil and sprinkle of Italian herbs with sesame seeds

14/05/2025

💗😴💗

Scientists have discovered that norepinephrine, released in rhythmic waves during deep sleep, drives the brain’s glymphatic system, which pumps cerebrospinal fluid to clear toxins. However, sleep aids like zolpidem may disrupt this process, reducing the brain’s cleaning efficiency.

Researchers in Denmark discovered that norepinephrine plays a crucial role in the brain cleaning process, at least in mice. During deep sleep, the brainstem releases waves of norepinephrine roughly every 50 seconds. These waves cause blood vessels in the brain to contract, creating slow, rhythmic pulsations that propel surrounding fluid to carry away waste effectively. The scientists found that norepinephrine waves correlate to variations in brain blood volume, suggesting it triggers a rhythmic pulsation in blood vessels. They then compared the changes in blood volume to brain fluid flow and found that brain fluid flow fluctuates in correspondence to blood volume changes, suggesting that the vessels act as pumps to propel the surrounding brain fluid to flush out waste.

“It’s like turning on the dishwasher before you go to bed and waking up with a clean brain,” says senior author Maiken Nedergaard of the University of Rochester and University of Copenhagen, Denmark.

“You can view norepinephrine as this conductor of an orchestra,” says lead author Natalie Hauglund of the University of Copenhagen and the University of Oxford, UK. “There’s a harmony in the constriction and dilation of the arteries, which then drives the cerebrospinal fluid through the brain to remove the waste products.”
Hauglund then had another question: is all sleep created equal? To find out, the researchers gave mice zolpidem, a common drug to aid sleep. They found that the norepinephrine waves during deep sleep were 50% lower in zolpidem-treated mice than in naturally sleeping mice. Although the zolpidem-treated mice fell asleep faster, fluid transport into the brain dropped by more than 30%. The findings suggest that the sleeping drug may disrupt the norepinephrine-driven waste clearance during sleep.

“More and more people are using sleep medication, and it’s really important to know if that’s healthy sleep,” says Hauglund. “If people aren’t getting the full benefits of sleep, they should be aware of that so they can make informed decisions.”
The team says that the findings likely apply to humans, who also have a glymphatic system, although this needs further testing. Other researchers have observed similar norepinephrine waves, blood flow patterns, and brain fluid flux in humans. Their findings may offer insights into how poor sleep may contribute to neurological disorders like Alzheimer’s disease.

For more on this study, see: https://scitechdaily.com/ambiens-hidden-risk-how-zolpidem-may-damage-your-brains-cleanup-system/

14/05/2025